Australia's largest stock trading and investment forum Australia's #1 stock forum

MYX mayne pharma group limited

0.20%

$5.08

I would wait to see who Mithra appoints to the board as the...

First 14 Last

Share
Profile

Follow
cjlt

166 Posts.

23

27/08/21

13:45

Post #: 55627181
Share

Originally posted by Superheat: ↑

I did own this stock but got out a long time back. I have watched it with interest ever since as every announcement they make seems to infuse hope that they have turned the corner. However that corner keeps fading into the distance everytime they get near it.

Having said all that, the chart of the revenue breakup does indicate promise of better things. Taking all emotion aside, blind Freddy should be able to improve it from this crazy low point. Would this be the time for a new entrant to buy in a contrarian move, on the assumption they will finally make money on the new contraceptive which looks really promising. Appreciate feedback from those who understand this stock and market well. (Chartsshout, please don't respond as you keep trotting out the same lines).

Expand

I would wait to see who Mithra appoints to the board as the company needs new management to breathe life back into it.

If they are good then hopefully with the other new appointments things will start looking up.

MYX Price at posting: 27.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

First 14 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.08		Change 0.010(0.20%)		Mkt cap ! $412.7M

Open	High	Low	Value	Volume
$5.13	$5.15	$5.08	$445.2K	87.01K

Buyers (Bids)

No.	Vol.	Price($)
1	810	$5.08

Sellers (Offers)

Price($)	Vol.	No.
$5.15	2033	2

View Market Depth

No.	Vol.	Price($)
1	810	5.080
1	905	5.060
1	1000	5.050
3	4055	5.040
1	600	5.030

Price($)	Vol.	No.
5.150	2033	2
5.170	905	1
5.180	2396	2
5.190	5905	2
5.200	157	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

MYX (ASX) Chart

I would wait to see who Mithra appoints to the board as the...

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I would wait to see who Mithra appoints to the board as the...

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News